Valuation: LeMaitre Vascular, Inc.

Market Cap 1.85B 1.66B 1.52B 1.38B 2.58B 176B 2.63B 18.18B 7.3B 92.45B 6.95B 6.8B 292B P/E 2026 *
28.2x
P/E 2027 * 25.5x
Enterprise Value 1.61B 1.44B 1.33B 1.2B 2.25B 153B 2.29B 15.82B 6.35B 80.44B 6.04B 5.92B 254B EV / Sales 2026 *
5.82x
EV / Sales 2027 * 5.12x
Free-Float
87.26%
Yield 2026 *
1.24%
Yield 2027 * 1.38%
1 day-5.08%
1 week-4.16%
Current month-2.00%
1 month-2.00%
3 months-20.79%
6 months-26.25%
Current year-0.20%
1 week 80.03
Extreme 80.03
85.81
1 month 78.31
Extreme 78.31
85.81
Current year 78.22
Extreme 78.22
118.01
1 year 78.22
Extreme 78.22
118.01
3 years 45.96
Extreme 45.96
118.01
5 years 38.32
Extreme 38.32
118.01
10 years 18.76
Extreme 18.76
118.01
Manager TitleAgeSince
Chief Executive Officer 61 1992-05-31
Director of Finance/CFO 51 2025-03-09
Director of Finance/CFO 62 1999-12-31
Director TitleAgeSince
Director/Board Member 68 2002-12-31
Chairman 61 2003-12-31
Director/Board Member 61 2016-10-23
Date Insider Type Main position Quantity % Market Cap. Importance
9/3/26 Free

Chairperson

24 0.0001%
9/3/26 Free

Director

6 0.0000%
9/3/26 Free

Chief Operating Officer

14 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-5.08%-4.16%-8.59%+68.98% 1.85B
-1.72%+3.44%+25.31%+60.56% 258B
-2.00%+0.75%+7.99%+25.46% 163B
-3.73%-4.48%-18.49%+67.13% 150B
-1.66%-8.12%-58.26%-16.12% 60.84B
-2.57%+3.30%+10.22%+47.55% 53.03B
0.00%+2.46%-11.97%-6.29% 53.31B
-3.47%+1.04%+21.98%+72.85% 49.3B
+0.84%-3.12%+9.80%+64.47% 50.67B
-3.61%+1.99%+34.94%+95.49% 45.46B
Average -2.30%-0.69%+1.29%+48.01% 88.53B
Weighted average by Cap. -2.11%+0.14%+5.16%+47.84%

Financials

2026 *2027 *
Net sales 277M 248M 228M 206M 386M 26.26B 393M 2.72B 1.09B 13.81B 1.04B 1.02B 43.56B 303M 271M 250M 226M 423M 28.77B 431M 2.98B 1.19B 15.13B 1.14B 1.11B 47.72B
Net income 66.71M 59.75M 54.96M 49.8M 93.08M 6.33B 94.83M 655M 263M 3.33B 250M 245M 10.51B 74.29M 66.53M 61.2M 55.45M 104M 7.05B 106M 730M 293M 3.71B 279M 273M 11.7B
Net Debt -240M -215M -198M -180M -336M -22.84B -342M -2.36B -948M -12.01B -903M -883M -37.88B -300M -269M -247M -224M -419M -28.52B -427M -2.95B -1.18B -15B -1.13B -1.1B -47.32B
Projected Income Statement - Annual - LeMaitre Vascular, Inc.
Logo LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. It develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which are used in open vascular surgery and dialysis access. It offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold globally in the United States, Europe, Canada and Asia Pacific.
Employees
651
Date Price Change Volume
26-10-30 $80.94 -5.08% 427,366
26-10-29 $85.27 +2.90% 300,113
26-10-28 $82.87 -1.10% 360,738
26-10-27 $83.79 -0.62% 221,961
26-10-26 $84.31 -0.17% 270,608
Trader
Investor
Global
Quality
ESG MSCI
CCC
MarketScreener Ratings - LeMaitre Vascular, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
80.94USD
Average target price
107.00USD
Spread / Average Target
+32.20%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LeMaitre Vascular, Inc.
  1. Stock Market
  2. Stocks
  3. LMAT Stock